Alzamend Neuro (NASDAQ: ALZN), a clinical-stage biotech company focused on treatments for Alzheimer’s and other neurological conditions, has announced a strategic collaboration with QMENTA, an…
May 07, 2025
Alzamend Neuro (NASDAQ: ALZN), a clinical-stage biotech company focused on treatments for Alzheimer’s and other neurological conditions, has announced a strategic collaboration with QMENTA, an…